Phase 4 Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with open-angle glaucoma or ocular hypertension (high eye pressure).
- People whose eye pressure in the study eye falls within the required range set by the trial (confirm with trial site for specific numbers).
Who may not be able to join:
- People whose eye pressure in the study eye is higher than 36 mmHg when not using any eye pressure-lowering medication.
- People who have had an allergic reaction or sensitivity to travoprost (a glaucoma eye drop medicine) or any of the ingredients in the travoprost eye implant used in this trial.
- People whose study eye has a cup-to-disc ratio greater than 0.8 — this is a measurement of the optic nerve at the back of the eye that indicates how much damage may have occurred (confirm with trial site if unsure what this means for a specific case).
- People whose best corrected vision (even with glasses) is worse than 20/80 in either eye.
- People who have any other eye disease or condition that, in the trial doctor's opinion, could put them at significant risk, affect the reliability of the trial results, or make it difficult to participate in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Study Director, Glaukos Corporation
Phone: 949-739-8749
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change from baseline in mean diurnal intraocular pressure (IOP)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.